Press Releases

Roswell Park adds the Capital Region to its Care Network with the addition of St. Peter's Health Partners

Combination therapy can attack against ovarian cancer and reduce the risk of relapse

Immunotherapy developed at Roswell Park targets deadliest type of brain cancer

Roswell Park team developing new ways to ‘armor’ immune cells against cancer.

Inaugural Physician Excellence in Cancer Care Awards recognize 5 Roswell Park doctors nominated by their peers

Roswell Park’s 2nd annual Pro Perspectives Speaker Symposium on October 8 welcomes journalist and cancer survivor Loriana Hernández-Aldama as the keynote speaker.

Roswell Park Comprehensive has made the inaugural Forbes list of America’s Best Employers for Healthcare Professionals, ranked 19th among employers nationwide.

Research presented by Roswell Park's Dr. Mark Farrugia at a major research meeting shows that a single, precise high dose of radiation less toxic but as effective as a traditional five-week course.

The results of the phase 1B/2 KOMET-001 clinical trial co-led by Roswell Park's Dr. Eunice Wang show that an investigational therapy produced deep, long-term responses in patients with recurrent or treatment-resistant acute leukemia marked by NPM1 mutations.